Business Context and Reporting Period
This Form 8-K is filed by 180 Life Sciences Corp. (not Forum Markets Inc.) on July 20, 2021. The report addresses the company's status regarding Nasdaq listing compliance. The company is an emerging growth company with common stock (ATNF) and warrants (ATNFW) listed on The NASDAQ Stock Market LLC.
Key Financial Metrics
This filing is a current report regarding corporate governance and listing status. It does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The filing text does not provide a clear value for any financial metric.
Material Changes
The primary material change reported is the resolution of a listing deficiency:
- Previous Status: The company was previously notified by Nasdaq of non-compliance with Listing Rule 5250(c)(1) due to the untimely filing of its 2020 Form 10-K and Q1 2021 Form 10-Q.
- Resolution: The company filed the 2020 Form 10-K on July 9, 2021, and the Q1 2021 Form 10-Q on July 19, 2021.
- Current Status: On July 19, 2021, Nasdaq notified the company that it has regained compliance and the matter is closed.
Outlook, Risks, and Management Commentary
Management Commentary: The company issued a press release on July 20, 2021, announcing the restoration of compliance with Nasdaq rules.
Risks and Contingencies: The filing highlights the risk of delisting associated with the failure to timely file periodic reports. This specific risk has been mitigated as of the filing date.
Guidance: No financial guidance or future outlook is provided in this document.
Investor Verification Checklist
- Verify the actual financial performance and liquidity position in the newly filed 2020 Form 10-K and Q1 2021 Form 10-Q referenced in this report.
- Confirm the company's continued compliance with Nasdaq listing standards beyond the filing of these specific reports.
- Review the attached press release (Exhibit 99.1) for any additional operational updates not detailed in the 8-K text.
- Note the discrepancy between the request metadata ("FORUM MARKETS Inc") and the actual registrant ("180 Life Sciences Corp").